Replimune to reintroduce melanoma drug after Makary leaves FDA
Thomas Fuller | Light rocket | fake images Replimune plans to resubmit its melanoma drug to the Food and Drug…
Thomas Fuller | Light rocket | fake images Replimune plans to resubmit its melanoma drug to the Food and Drug…
Eli Lilly on Thursday said its next-generation drug passed a crucial late-stage trial in obese patients, achieving significant weight loss…
President Donald Trump speaks to introduce the TrumpRx website in the South Court Auditorium of the White House in Washington,…
A Biogen facility in Cambridge, Massachusetts. Brian Snyder | Reuters biogen plans to advance an experimental Alzheimer's disease drug into…
Food and Drug Administration Commissioner Marty Makary speaks during an announcement at the Department of Health and Human Services on…
A Wegovy injection pen is shown in Waterbury, Vermont, on April 28, 2025. Shelby Knowles | Bloomberg | fake images…
Nordisk is looking for deals more than ever, the Danish drugmaker's CEO said Wednesday in an interview with CNBC. “If…
Exterior view of the Pfizer headquarters building on January 29, 2023 in New York City. See Press | Corbis News…
Eli Lilly on Thursday reported first-quarter earnings and revenue that beat estimates and raised its full-year sales outlook by $2…
When Branneisha Cooper began receiving the GLP-1 injection in Mounjaro in late 2022, she heard online that she could experience…